US-based functional mushroom specialist Om Mushrooms has secured a $6.5 million line of credit from asset-based lender JPalmer Collective (JPC).
The funding is earmarked to support the company’s next operational growth phase, enabling it to scale production and inventory to meet surging consumer demand for functional mushroom products across the supplements, beverages, and plant-based nutrition categories.
Strategic Capital for a Booming Sector
The financial agreement underscores the rapid mainstreaming of the functional mushroom market. JPC, a lender specialising in high-growth, women-led, and natural products businesses, views the sector as a critical area for future expansion.
Jennifer Palmer, Founder and CEO of JPalmer Collective, commented on the market dynamics: "Functional mushrooms have become one of the most exciting growth areas in natural wellness, and Om has been ahead of that curve for more than a decade."
The flexible credit line is designed to provide the working capital necessary for Om Mushrooms to navigate supply chain scaling and retail expansion as mushrooms transition from niche ingredients to staple functional additives.
Company Profile and Standards
Founded by health expert Dr Sandra Carter and veteran mycologist Steve Farrar, Om Mushrooms has established a reputation for quality over more than a decade of operation.
Sourcing: Products are grown in the United States under certified organic conditions.
Portfolio: The range includes powders, capsules, gummies, and functional beverages.
Health Focus: Formulations target specific wellness verticals including focus, immunity, stress relief, and gut health.






.jpg)

